BAG3-DCM Natural History Study
← catalyst calendarNCT07486752 · readout ≤ 2,326 d
Sponsored by Rocket Pharmaceuticals Inc. (industry) · RCKT — their whole pipeline →.
Phase
—
Status
Not yet recruiting
Study type
Observational
Enrollment
30estimated
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | May 2026 | estimated | When the study began enrolling |
| Primary completion | Dec 2032 | estimated | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | Mar 2033 | estimated | The whole study's end, after follow-up |
| First posted | 2026-03-20 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2026-03-20 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Conditions
- Dilated Cardiomyopathy (DCM)
- Cardiovascular Diseases
- Heart Diseases
- Genetic Diseases
Primary outcome
what the primary-completion date above is the date OFCardiac structure and function
measured 48 months
Permalink · RCKT's whole pipeline · Catalyst calendar · Every registered study · What changed